Personalized medicine in psychiatry: New technologies and approaches

Metabolism: Clinical and Experimental

Volumn 62, Issue SUPPL.1, 2013, Pages

  Costa e Silva, Jorge A ^a  

^a Brazilian Brain Institute   (Brazil)

Author keywords

Copy number variation; Hippocampus; Prefrontal cortex; Schizophrenia

Indexed keywords

CYTOCHROME P450 2C19; CYTOCHROME P450 2D6;

ARTICLE; ATTENTION DEFICIT DISORDER; BIPOLAR DISORDER; BORDERLINE STATE; DIFFUSION TENSOR IMAGING; DISEASE COURSE; DNA MICROARRAY; DOPAMINERGIC SYSTEM; DRUG DEVELOPMENT; DRUG EFFICACY; DRUG MONITORING; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENE DUPLICATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HEALTH CARE COST; HERITABILITY; HUMAN; MAGNETOENCEPHALOGRAPHY; MENTAL DISEASE; MONITORING; NERVE CELL NETWORK; NEUROIMAGING; NEUROTRANSMISSION; PERSONALIZED MEDICINE; PHARMACOGENETICS; PHENOTYPE; PRIORITY JOURNAL; PSYCHIATRY;

ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; CYTOCHROME P-450 CYP2D6; CYTOCHROME P-450 ENZYME SYSTEM; DIFFUSION TENSOR IMAGING; DNA COPY NUMBER VARIATIONS; ELECTROENCEPHALOGRAPHY; GENOTYPE; HIPPOCAMPUS; HUMANS; INDIVIDUALIZED MEDICINE; MAGNETIC RESONANCE IMAGING; MAGNETOENCEPHALOGRAPHY; MENTAL DISORDERS; NERVE NET; NEUROIMAGING; PHARMACOGENETICS; POLYMORPHISM, GENETIC; POSITRON-EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PSYCHIATRY; PSYCHOTROPIC DRUGS;

EID: 84870572847     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2012.08.017     Document Type: Article

References (14)

1. J. de Leon The future (or lack of future) of personalized prescription in psychiatry Pharmacol Res 59 2 2009 81 89
2. M.V. Holmes, T. Shah, C. Vickery, L. Smeeth, A.D. Hingorani, and J.P. Casas Fulfilling the promise of personalized medicine? Systematic review and field synopsis of pharmacogenetic studies PLoS One 4 12 2009 e7960
3. K.W. Lee, P.S. Woon, Y.Y. Teo, and K. Sim Genome wide association studies (GWAS) and copy number variation (CNV) studies of the major psychoses: what have we learnt? Neurosci Biobehav Rev 36 1 2012 Jan 556 571
4. A.L. Barabasi, N. Gulbahce, and J. Loscalzo Network medicine: a network-based approach to human disease Nat Rev Genet 12 1 2011 Jan 56 68
5. J. de Leon AmpliChip CYP450 test: personalized medicine has arrived in psychiatry Exp Rev Mol Diagn 6 3 2006 277 286
6. B.N. Yu, C.H. Luo, D. Wang, A. Wang, Z. Li, and W. Zhang CYP2C9 allele variants in Chinese hypertension patients and healthy controls Clin Chim Acta 348 1-2 2004 Oct 57 61
7. Y. Zhou, N. Shu, Y. Liu, M. Song, Y. Hao, and H. Liu Altered resting-state functional connectivity and anatomical connectivity of hippocampus in schizophrenia Schizophr Res 100 1-3 2008 Mar 120 132
8. N.D. Woodward, B. Rogers, and S. Heckers Functional resting-state networks are differentially affected in schizophrenia Schizophr Res 130 1-3 2011 Aug 86 93
9. R.C. Wolf, F. Sambataro, N. Vasic, M. Schmid, P.A. Thomann, and S.D. Bienentreu Aberrant connectivity of resting-state networks in borderline personality disorder J Psychiatry Neurosci 36 6 2011 Nov 402 411
10. T. Sheng, A. Gheytanchi, and L. ziz-Zadeh Default network deactivations are correlated with psychopathic personality traits PLoS One 5 9 2010 e12611
11. C. Esslinger, P. Kirsch, L. Haddad, D. Mier, C. Sauer, S. Erk, and A. Meyer-Lindenberg Cognitive state and connectivity effects of the genome-wide significant psychosis variant in ZNF804A Neuroimage 54 3 2011 Feb 1 2514 2523
12. N.J. Bray, F.M. Leweke, S. Kapur, and A. Meyer-Lindenberg The neurobiology of schizophrenia: new leads and avenues for treatment Neuroimage 54 3 2011 Feb 1 2514 2523
13. H. Walter, K. Schnell, S. Erk, C. Arnold, P. Kirsch, and A. Meyer-Lindenberg Effects of a genome-wide supported psychosis risk variant on neural activation during a theory-of-mind task Mol Psychiatry 16 4 2011 Apr 462 470
14. J. Weide, and J. Hinrichs Personalized medicine: pharmacogenetics in psychiatry Pharmacogenomics Personalized Med 6 1 2008 March 1 11